COMMUNIQUÉS West-GlobeNewswire

Kura Oncology Reports Fourth Quarter and Full Year 2018 Financial Results

05/03/2019 - 22:03

– Registration-directed trial of tipifarnib in HRAS mutant HNSCC underway – – Data from three ongoing Phase 2 trials of tipifarnib anticipated this year – – Third drug candidate menin-MLL inhibitor KO-539 poised to [...]

Sarepta Therapeutics Announces Proposed $350,000,000 Public Offering of Common Stock

05/03/2019 - 22:02

CAMBRIDGE, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today announced that it is offering to sell, subject to market [...]

Cara Therapeutics to Announce Fourth Quarter and Full Year 2018 Financial Results on March 12, 2019

05/03/2019 - 22:01

STAMFORD, Conn., March 05, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and commercializing new chemical entities with a primary focus on the [...]

Mersana Therapeutics Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

05/03/2019 - 22:01

CAMBRIDGE, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (Nasdaq:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]

Ziopharm Oncology Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Corporate Update

05/03/2019 - 22:01

- Phase 1 Trial of Sleeping Beauty -TCR-T cell therapy for patients with solid tumors to begin at National Cancer Institute in mid-2019 – - Third-generation Sleeping Beauty CD19-specific CAR-T U.S. trial to begin in [...]

CymaBay Announces Proposed Public Offering of Common Stock

05/03/2019 - 22:01

NEWARK, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (Nasdaq: CBAY), a clinical-stage biopharmaceutical company focused on developing and providing access to innovative therapies for patients [...]

Gritstone Oncology to Present at Two Upcoming Investor Conferences in March

05/03/2019 - 22:00

EMERYVILLE, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Gritstone Oncology (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, [...]

Dermira to Present at the Cowen and Company 39th Annual Health Care Conference

05/03/2019 - 22:00

MENLO PARK, Calif., March 05, 2019 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ: DERM), a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies [...]

Crown Bioscience and The Jackson Laboratory Collaboration Enables Global Access to FATZO Mouse Model

05/03/2019 - 21:35

Continued Collaboration Facilitates Global Distribution of Obesity, Metabolic Disease, and NASH Model and Priority Supply to CrownBio’s World-Class Cardiovascular, Obesity, and Metabolic Disease Platform SAN DIEGO, [...]

Christina Lake Cannabis Announces License Application

05/03/2019 - 18:55

VANCOUVER, British Columbia, March 05, 2019 (GLOBE NEWSWIRE) -- Christina Lake Cannabis Corp. (“ CLC ” or the “ Company ”) is pleased to announce that it submitted its application for a Standard Cultivation License [...]

Kiadis Pharma Strengthens Management Team

05/03/2019 - 17:46

Kiadis Pharma Strengthens Management Team Dirk de Naeyer appointed Chief Operations Officer and Martine Nolan as Head of Quality Assurance, effective March 1, 2019 Amsterdam, The Netherlands, March 5, 2019 - Kiadis [...]

Infant Bacterial Therapeutics AB announces first distribution agreement

05/03/2019 - 17:10

Infant Bacterial Therapeutics AB has today signed the first distribution agreement for IBP-9414 with Megapharm Ltd. for the Israeli market and the Palestinian Authority’s territories. The agreement gives MegaPharm [...]

BrainsWay Announces New Clinical Support Program for Physicians Treating Obsessive-Compulsive Disorder: – “BrainsWay OCD Launchpad to Success”

05/03/2019 - 17:09

Program supports physicians in successfully implementing OCD Deep TMS treatment, through in-depth clinical guidance and patient awareness campaigns HACKENSACK, N.J., March 05, 2019 (GLOBE NEWSWIRE) -- BrainsWay Ltd. ( [...]

Easton Signs Agreement to Acquire Commercial Bakery with Projected Revenues Over $20,000,000 per Year and Positioned to Enter the Cannabis Edibles Market

05/03/2019 - 16:56

TORONTO, ON, March 05, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Easton Pharmaceuticals Inc. (OTC: EAPH ) announces that it has signed an agreement to acquire a commercial bakery with existing revenues and projected [...]

B. Braun Displays Ongoing Commitment to Home and Specialty Infusion Therapy at NHIA 2019

05/03/2019 - 16:25

BETHLEHEM, Pa., March 05, 2019 (GLOBE NEWSWIRE) -- B. Braun Medical Inc. will showcase its extensive portfolio of products, services, and technology at this year’s National Home Infusion Association (NHIA) Conference [...]

Reporting of transactions in Orphazyme’s shares made by persons discharging managerial responsibilities

05/03/2019 - 15:51

Orphazyme A/S Company announcement No. 07/2019 Company Registration No. 32266355 Copenhagen, Denmark, March 5, 2019 – Pursuant to the Market Abuse Regulation article 19, Orphazyme A/S, CVR no. 32266355 (“Orphazyme”), [...]

Olainfarm Holds Fourth Quarter 2018 Investor Conference - Webinar

05/03/2019 - 15:34

AS Olainfarm invites shareholders, investors, mass media representatives and other stakeholders to join its investor conference - webinar scheduled on March 5, 2019 at 16:00 (EET). To join the webinar please follow the [...]

Eloxx Pharmaceuticals to Present at the Oppenheimer 29th Annual Healthcare Conference on March 20, 2019

05/03/2019 - 15:08

WALTHAM, Mass., March 05, 2019 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics to treat cystic [...]

RepScrubs® Appoints Former CMS Administrative Director, Charlene Frizzera to Advisory Board to Continue Improving Infection Control in Hospitals

05/03/2019 - 15:05

Company limiting the transfer of pathogens in operating rooms expands advisory board to include former COO at The Center for Medicare and Medicaid Services ORLANDO, Fla., March 05, 2019 (GLOBE NEWSWIRE) -- Prescient [...]